Ackman says Valeant stock 'extraordinary bargain'

(Reuters) - Activist investor Bill Ackman said Valeant Pharmaceuticals International Inc's (NYSE: VRX) (NYSE: VRX) stock was an "extraordinary bargain" given its low price.

More doctors could use specialty pharmacies, potentially benefiting Valeant, and the selloff in the stock was unwarranted, Ackman said on Pershing Square's quarterly call on Monday.

He also said he had constructive meeting with the management of Mondelez International Inc (NASDAQ: MDLZ), in which he took a stake in August.

(Reporting by Sruthi Ramakrishnan in Bengaluru; Editing by Sriraj Kalluvila)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Activist Ancora Now Seeks to Buy H.B. Fuller Adhesives Unit - Bloomberg
• Lionsgate faces activist pressure to sell itself in ‘AI era’ - Semafor
• Quantum Cyber sues White Diamond Research and Stocktwits over short-sell report